JPRN-UMIN000013017已完成未知
Efficacy and safety of simeprevir/pegylated-interferon/ribavirin combination therapy with Vitamin D3 in chronic hepatitis C patients: multi-center, open label, randomized, controlled study - Simeprevir/peg-interferon/ribavirin combination therapy with or without Vitamin D3
ippon Medical School Chiba Hokusoh Hospital0 个研究点目标入组 150 人开始时间: 2014年1月30日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. other liver diseases, including autoimmune hepatitis, primary biliary cirrhosis, and alcoholic disease 2. positive result for hepatitis B surface antigen and antibody to human immunodeficiency virus type-1 3. decompensated liver cirrhosis 4. severe renal disorder 5. pregnant woman or lactating mother 6. allergy to IFN, ribavirin, protease inhibitor or biological preparations such as vaccines. 7. poorly controlled diabetes; poorly controlled heart failure;poorly controlled hypertension 8. medication with Chinese herbal medicine 9. medical history of interstitial pneumonia 10. severe depression 11. hyperparathyroidism 12. hypercarcemia 13. medication with other vitamin D preparations
研究者
相似试验
尚未招募
不适用
Efficacy and safety of simeprevir with pegylated interferon alfa and low dose of ribavirin for patients with chronic hepatitis C genotype 1 and low hemoglobin levelJPRN-UMIN000018476Osaka University Graduate School of Medicine, Department of Gastroenterology and Hepatology55
尚未招募
不适用
Efficacy and safety of simeprevir with pegylated interferon alfa and ribavirin in patients with chronic hepatitis CPatients with chronic hepatitis C virus infectionJPRN-UMIN000012183Osaka University Graduate School of Medicine, Department of Gastroenterology and Hepatology500
已完成
不适用
Efficacy and safety of simeprevir with pegylated interferon alfa-2b and ribavirin in kidney transplant patients with chronic hepatitis CPatients with chronic hepatitis C virus infectionJPRN-UMIN000013088Osaka University18
已完成
不适用
Efficacy and safety of simeprevir plus pegylated intereferon combination therapy for HCV genotype 1 patients with chronic renal failurechronic infection with hepatitis C virusJPRN-UMIN000012668Osaka University Graduate school of Medicine45
招募中
不适用
Efficacy and safety of Simeprevir/PEG alpha-IFN-2a/RBV therapy for patients with chronic hepatitis C after resection of hepatocellular carcinomaChronic hepatitis CJPRN-UMIN000012937Kansai Medical University100